Back to Markets
RCRocket Pharmaceuticals Inc

Rocket Pharmaceuticals Inc

RCKTNASDAQ NMS - GLOBAL MARKET
Health CareBiotechnology

$3.07

+0.0500 (+1.66%)

As of 05/29/26 EDT · USD

Compare
Low: $2.40Current: $3.07High: $5.45

Key Statistics

Open

$3.02

Day High

$3.08

Day Low

$2.98

Prev. Close

$3.02

VolumeShares traded today.

2.18M

Avg. VolumeAverage daily volume.

Market CapTotal value of all shares = price × shares outstanding.

$335.22M

P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.

-1.64

Forward P/EP/E based on forecast next-year earnings.

P/B RatioPrice-to-Book: share price ÷ book value per share.

52W HighHighest price over the past 52 weeks.

$5.45

52W LowLowest price over the past 52 weeks.

$2.40

50D MAAverage closing price over the last 50 trading days.

$3.60

200D MAAverage closing price over the last 200 trading days.

$3.57

Dividend YieldAnnual dividend ÷ share price, as a %.

BetaVolatility vs the market. >1 = more volatile than the S&P 500.

Performance

1W

-1.3%

1M

-11.8%

6M

-1.0%

YTD

-11.3%

1Y

+10.8%

About

Regenerative Medicine Advanced Therapy (RMAT) is a designation given by the Food and Drug Administration to drug candidates intended to treat serious or life-threatening conditions under the 21st Century Cures Act. A RMAT designation allows for accelerated approval based surrogate or intermediate endpoints.

www.rocketpharma.com/

Company Facts

SectorHealth Care
IndustryBiotechnology
ExchangeNASDAQ NMS - GLOBAL MARKET
CurrencyUSD

Sentiment

Latest News

Social Noise

Price Alerts

Loading…

Trade RCKT

Brokers available in your region (US)

Affiliate links — we may earn a commission. CFDs are risky.